In Follow-up
Prostate
In Follow-up
ENZAMET
ANZUP 1304
NSW | VIC | QLD | NT | SA | TAS | WA | NZ | UK | Ireland | Canada | USA
Enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: a randomised phase III trial
Prostate
In Follow-up
ENZARAD
ANZUP 1303
NSW | VIC | QLD | SA | TAS | WA | NZ | UK | Ireland | Belgium | USA | Spain | Austria | Slovenia
Enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: a randomised phase III trial
Prostate
In Follow-up
Pain-Free TRUS B
ANZUP 1501
NSW | VIC | WA | NZ
A phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasound-guided prostate biopsy
Bladder
In Follow-up
PCR MIB
ANZUP 1502
NSW | VIC | WA
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Prostate
In Follow-up
proPSMA
HREC/16/PMCC/130
NSW | VIC | QLD | SA | WA
A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy
Prostate
In Follow-up
TheraP
ANZUP 1603
NSW | VIC | QLD | SA | WA
A randomised phase II trial of 177Lu-PSMA617 theranostic versus cabazitaxel in progressive metastatic castration resistant prostate cancer
Kidney
In Follow-up
UNISoN
ANZUP 1602
NSW | VIC | QLD | SA | WA
UNISoN: anzUp Nivo -> Ipi + Nivo Sequential Non-clear cell Proposed phase II sequential cohort trial of single agent Nivolumab, then combination Ipil…
Kidney
In Follow-up
FASTRACK II
TROG 15.03
NSW | VIC | QLD | SA
TROG 15.03 Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney – A Phase II Clinical Trial
Bladder
In Follow-up
NMIBC-SI Evaluation
N/A
NSW | VIC | QLD | WA | NZ | UK | Canada | USA
Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer